Cns Pharmaceuticals Inc

NASDAQ:CNSP   9:42:29 AM EDT
1.78
0.00 (0.00%)
Products

FDA Grants Fast Track Designation To CNS Pharmaceuticals For Berubicin For The Treatment Of Recurrent Glioblastoma Multiforme

Published: 06/29/2021 13:18 GMT
Cns Pharmaceuticals Inc (CNSP) - FDA Grants Fast Track Designation to Cns Pharmaceuticals for Berubicin for the Treatment of Recurrent Glioblastoma Multiforme.